Overview Fundamentals API Earnings EOD API Sample Code Pricing

Zymeworks Inc. Common Stock (ZYME NASDAQ) stock market data APIs

$17.23 0.51(3.1%) as of November 14, 2024
Price chart is built with Anychart

Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a human epidermal growth factor receptor 2 (HER2) that is in Phase 1, Phase 2, and Phase 3 clinical trials, including certain ongoing pivotal clinical trials; and zanidatamab zovodotin, a HER2 -targeted antibody-drug conjugate that is in Phase 2 clinical trial for the treatment of advanced or metastatic HER2-expressing tumors. It also develops a pipeline of preclinical product candidates and discovery-stage programs in oncology, including immuno-oncology agents and other therapeutic areas. Zymeworks Inc. has strategic partnerships and collaborations with BeiGene, Ltd.; Celgene Corporation; Celgene Alpine Investment Co. LLC; GlaxoSmithKline Intellectual Property Development Limited; Daiichi Sankyo Co., Ltd.; Janssen Biotech, Inc.; LEO Pharma A/S; Iconic Therapeutics, Inc.; Merck Sharp & Dohme Research GmbH; and Atreca, Inc. Zymeworks Inc. was incorporated in 2003 and is based in Middletown, Delaware.

Zymeworks Inc. Common Stock Financial Data Overview

16.72
17.23
-
17.37
16.51
7.8-17.7
1 185 M
68 878 K
62 199 K
-0.39
1.157
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'ZYME',
Type: 'Common Stock',
Name: 'Zymeworks Inc. Common Stock',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG019XSYC89',
ISIN: 'CA98985W1023',
CUSIP: '98985W102',
CIK: '1403752',
EmployerIdNumber: '47-2569713',
FiscalYearEnd: 'December',
IPODate: '2017-04-28',
InternationalDomestic: 'Domestic',
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'Domestic',
IsDelisted: false,
}

Zymeworks Inc. Common Stock Fundamental Data is available in our Financial Data APIs

  • Net Revenue 62 199 K
  • EBITDA -114 707 000
  • Earnings Per Share -1.49
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Zymeworks Inc. Common Stock Earnings via APIs

  • Latest Release 2024-10-31
  • EPS/Forecast -0.4

Get Zymeworks Inc. Common Stock End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com